Mulugeta T ANGAMO, Adugna TESFA, Nasir Tajure WABE

Knowledge, attitude and practice of adverse drug reaction reporting among health professionals in Southwest Ethiopia

AMAÇ: İlaç yan etkisi; tanı, tedavi veya profilaksi için insanlarda kullanılan dozdaki ilaca ortaya çıkan karşı tehlikeli ve istenmeyen reaksiyondur. İlaç yan etkisi takibi, henüz az dikkat edilen bir ilaç bilgisi alanıdır. Kendi kendine (spontan) bildirim halen ilaç yan etkilerini tespit etmek için temel dayanaktır. Bu çalışmanın amacı Güneybatı Etiyopya’da seçilmiş sağlık tesislerindeki sağlık profesyonelleri arasında ilaç yan etkisi bildirme bilgi, tutum ve davranışını değerlendirmektir. YÖNTEM: Ocak 2010’da seçilmiş sağlık tesislerindeki sağlık profesyonelleri arasında kesitsel çalışma dizaynı kullanıldı. Hekim dışı reçete düzenleyenler, eczane teknisyenleri ve yardımcı sağlık personeli çalışma dışı bırakıldı. Veriler gönüllü hekimlerden (intörn ve üzeri), hemşirelerden ve eczacılardan kendi kendine uygulanan soru formu ile toplandı ve SPSS version 16.0 kullanılarak analiz edildi.. BULGULAR: Çalışmaya 82 sağlık profesyoneli katıldı. Bunlardan sadece 19 (%23,17)’u ve 21 (%25,61)’i ulusal bir rapor sistemi olduğunu ve ilaç yan etkisini rapor etmek için sarı kart kullanıldığını bilmekteydi. Onbeş (%15,85) katılımcı kendi klinik uygulamaları sırasında son oniki ayda ilaç yan etkisi ile karşılaştı, fakat hiçbir sorumlu kişiye bildirmedi. Katılımcıların bilgi ve uygulaması yeterli olmasa da, yanıtlayanların 47 (%57,31)’i ilaç yan etkisini bildirmenin görevlerinin bir parçası olduğu ve genelde toplum için, özelde hasta için önem taşıdığ konusunda hemfikirlerdi. SONUÇ: Bizim çalışmamız; sağlık çalışanları arasında ilaç yan etkisi bildirmede farkındalık oluşturmak ve teşvik etmek için büyük bir gereksinim olduğunu güçlü bir şekilde önerir. Bil gi yokluğu ve kendi kendine bildirme hakkındaki yanlış düşünceler ile kısmen açıklanabilecek, ilaç yan etkisi bildirimi ve belgelemesi yoktur

Güneybatı Etiyopya’da sağlık profesyonelleri arasında ilaç yan etkisi bildirme bilgi, tutum ve uygulaması

AIM: Adverse drug reaction is noxious and unwanted reaction to drugs at dose used in humans for diagnosis, treatment or prophylaxis. Adverse drug reaction monitoring is an area of drug information that has been given little attention yet. Spontaneous reporting is currently the major back bone for the detection of adverse drug reactions. The objective of this study was to assess the knowledge, attitude and practices of adverse drug reaction reporting among health professionals in selected health facilities in southwest Ethiopia. METHOD: A cross-sectional study design was used among health professionals in selected health facilities in January 2010. Prescribers other than physicians, junior pharmacy technicians and also health assistants were excluded. Data was collected using self administered questionnaires from volunteered physicians (Medical interns and above), nurses (Diploma and above) and Pharmacy professionals (Diploma and above) and analyzed using SPSS version 16.0. RESULTS: A total of 82 health professionals were participated in the study. From those 82 participants, only 19 (23.17%) and 21 (25.61%) knew the existence of national reporting system and a yellow card of adverse drug reaction reporting form. Thirteen (15.85%) participants encountered adverse drug reaction in the past 12 months in their clinical activities, but none of them reported to responsible body. Even though the participants’ knowledge and practice were inadequate, most of the respondents 47 (57.31%) agreed that adverse drug reaction reporting is part of duty of them and important to the public in general and to the patient in particular. CONCLUSION: There was no documentation and reporting of adverse drug reaction, which might partly be explained by lack of knowledge and misconceptions about spontaneous reporting. Our study strongly suggests that there is a great need to create awareness and to promote the reporting of adverse drug reaction amongst health professionals, which will lay a solid foundation for healthcare professionals to be diligently involved in quality pharmacovigilance and spontaneous reporting in their future practices.

PDF

___

1. Guideline for Adverse Drugs Reaction (ADR) Monitoring,2nd Edition, September 2008, DACA, Addis Ababa, Ethiopia.
2. WHO, A Guideline to detecting and reporting adverse drug reactions, Geneva, 2001.
3. WHO, Safety Monitoring of Medical Products: Guidelines for setting up and running a pharmacovigilance center, the Uppsala monitoring center, 2000.
4. Adverse Drug Reaction in hospital patients. A systematic review of prospective studies. Bandolier Extra. 2002, p. 1-16.
5. A Meta analysis of prospective studies, Journal of American Medical Association. 1998; 279; 1200-1205.
6. Drug related morbidity and mortality: Updating the cost of illness model, Journal of American Medical Association, 2001.
7. Vassel G, Mardani Z, Mollai M. Knowledge, Attitudes and Perceptions of pharmacists to adverse drug reaction reporting in Iran, Pharm World Sci. 2009; 31(2); 183-187.
8. Kazeem A, Jacob O. Perceptions of doctors to adverse drug reaction reporting in teaching hospital in Lagos, Nigeria, BMC clinical pharmacology. 2009; 9: 14.
9. Christopher F, David R, Philip H, Munir P. Knowledge and Attitude of UK hospital pharmacists to adverse drug reaction reporting, Br J Pharmcol. 2001; 51(1); 81-86.
10. Rehans H, Vasudeuk T. Knowledge, attitude and practices of medical students and prescribers on adverse drug reaction monitoring, Natl Med J India. 2002; 15(1): 24-26. Lady Herdinga Medical College, New Delhi, India.
11. Mohammed S, Alsultan S, Bawazir A. Adverse drug reaction reporting by hospital pharmacists in Saudi Arabia. Saudi Arabia pharmaceutical journal. 2009; 17(1):
12. Toklu H, Uysal M. Knowledge and attitude of Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul, Pharm World Sci. 2008; 30(5): 556-562.
13. Van A, Mes K, De Jong-Van L, Den B. Attitudes of community pharmacists in Netherlands towards adverse drug reaction reporting, Int. J Pharm Pract. 2002; 10; 267-272.
14. Monica Z, Nirasha P. Adverse drug reaction reporting in New Zealand. The Clin Risk Manag. 2005; 1(3): 181-188.
15. Gupta P. Adverse drug reaction reporting and Pharmacovigilence: Knowledge, attitude and perception amongst resident doctors, Journal of Pharmaceutical Sciences and Research. 2011; 1:
16. Subish P, Izham MM, Mishra P. Evaluation of the knowledge, attitude and practices on adverse drug reactions and pharmacovigilance among healthcare professionals in a Nepalese hospital: a preliminary study. The Internet Journal of Pharmacology. 2008; 6(1)